You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Radium-223

Showing 1 - 25 of 161
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Learn More About How Radium-223 is Being Used With Other

Active, not recruiting
  • Bone Metastatic Castration-resistant Prostate Cancer
  • Radium 223 dichloride (Xofigo, BAY88-8223)
  • Multiple Locations, Denmark
  • +2 more
Jan 16, 2023

Biochemical Recurrent Prostate Cancer Trial run by the National Cancer Institute (NCI) (Radium-223, 18F Sodium Fluoride)

Recruiting
  • Biochemical Recurrent Prostate Cancer
  • Radium-223
  • 18F Sodium Fluoride
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Feb 2, 2023

Metastatic Prostate Cancer Trial (Darolutamide, Radium-223)

Not yet recruiting
  • Metastatic Prostate Cancer
  • (no location specified)
Mar 6, 2023

Learn More About How Radium-223 Affects Quality of Life of

Recruiting
  • Prostate Cancer
  • Radium-223-dichloride (Xofigo, BAY88-8223)
  • Multiple Locations, Colombia
    Many Locations
Jan 19, 2023

Prostate Cancer Trial in Boston (Radium-223, Pembrolizumab)

Active, not recruiting
Has Results
  • Prostate Cancer
  • Boston, Massachusetts
  • +1 more
Aug 31, 2022

Metastatic Castration-resistant Prostate Cancer, mCRPC, Prostate Cancer Trial in Melbourne (Lutetium-177 PSMA-I&T, Radium-223)

Recruiting
  • Metastatic Castration-resistant Prostate Cancer
  • +2 more
  • Lutetium-177 PSMA-I&T
  • Radium-223
  • Melbourne, Victoria, Australia
    Peter MacCallum Cancer Centre
Sep 26, 2022

How Radium-223 Dichloride,Alpha Particle-emitting Radioactive

Recruiting
  • Castration-resistant Prostate Cancer
  • Radium-223 dichloride (Xofigo, BAY88-8223)
  • Multiple Locations, Taiwan
    Many locations
Aug 19, 2022

Radium-223 is and How Well it Works in Chinese Advanced Prostate

Not yet recruiting
  • Metastatic Castration-resistant Prostate Cancer
  • Bone Metastases
  • Radium-223 dichloride (Xofigo, BAY88-8223)
  • Multiple Locations, China
    Many locations
Aug 10, 2022

Prostate Cancer Trial in Baltimore (Radium-223, stereotactic ablative radiotherapy (SABR))

Recruiting
  • Prostate Cancer
  • Radium-223
  • stereotactic ablative radiotherapy (SABR)
  • Baltimore, Maryland
    Johns Hopkins
May 25, 2022

Metastatic Castration-resistant Prostate Cancer Trial in Myrtle Beach (Darolutamide, Enzalutamide, Radium-223)

Terminated
Has Results
  • Metastatic Castration-resistant Prostate Cancer
  • Enzalutamide during Lead-in Period
  • +5 more
  • Myrtle Beach, South Carolina
    Research Site
Sep 9, 2022

Castration-Resistant Prostate Carcinoma, Metastatic Malignant Tumor in the Bone, Stage IVB Prostate Cancer AJCC v8 Trial in San

Not yet recruiting
  • Castration-Resistant Prostate Carcinoma
  • +2 more
  • Radium-223
  • +2 more
  • San Francisco, California
    University of California, San Francisco
Jun 20, 2023

Castration-Resistant Prostate Carcinoma, Metastatic Malignant Tumor in the Lymph Nodes, Metastatic Prostate Carcinoma Trial in

Recruiting
  • Castration-Resistant Prostate Carcinoma
  • +3 more
  • Los Angeles, California
  • +22 more
Feb 2, 2023

Prostate Cancer Trial in Houston (Alpharadin)

Completed
Has Results
  • Prostate Cancer
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Feb 16, 2022

Treatment Satisfaction With Ra-223 in Japan

Active, not recruiting
  • Prostatic Neoplasms
  • Radium-223 dichloride (Xofigo, BAY88-8223)
  • Multiple Locations, Japan
    Many Locations
Jan 12, 2023

Prostate Adenocarcinoma Trial in Duarte (drug, radiation, other)

Recruiting
  • Prostate Adenocarcinoma
  • Leuprolide Acetate
  • +5 more
  • Duarte, California
    City of Hope Medical Center
Sep 14, 2022

Metastatic Castration-resistant Prostate Cancer Trial in Salt Lake City (Nivolumab)

Recruiting
  • Metastatic Castration-resistant Prostate Cancer
  • Salt Lake City, Utah
    Huntsman Cancer Institute at University of Utah
Apr 21, 2022

Castration-Resistant Prostate Carcinoma, Metastatic Prostate Adenocarcinoma, Stage IVB Prostate Cancer AJCC v8 Trial in United

Recruiting
  • Castration-Resistant Prostate Carcinoma
  • +2 more
  • Laboratory Biomarker Analysis
  • +3 more
  • La Jolla, California
  • +21 more
Dec 2, 2022

Patients and Other Factors Which May Contribute to Survival

Completed
  • Metastatic Castration Resistant Prostate Cancer (mCRPC)
  • Radium-223 dichloride (Xofigo, BAY88-8223)
  • Whippany, New Jersey
    Bayer Flatiron Xofigo Registry database
Mar 17, 2022

Non-study Population of Symptomatic mCRPC Patients Treated With

Active, not recruiting
  • Prostate Cancer Metastatic
  • Bone Metastases
  • Blood tests
  • Amsterdam, Netherlands
  • +1 more
Apr 20, 2022

Anatomic Stage IV Breast Cancer AJCC v8, Hormone Receptor-Positive Breast Carcinoma, Metastatic Breast Carcinoma Trial in United

Recruiting
  • Anatomic Stage IV Breast Cancer AJCC v8
  • +5 more
  • Biospecimen Collection
  • +4 more
  • Birmingham, Alabama
  • +26 more
Jan 25, 2023

Bone Metastatic Castration-resistant Prostate Cancer Trial in Worldwide (Radium-223 dichloride (Xofigo, BAY88-8223))

Recruiting
  • Bone Metastatic Castration-resistant Prostate Cancer
  • Radium-223 dichloride (Xofigo, BAY88-8223)
  • Linz, Oberösterreich, Austria
  • +15 more
Aug 24, 2022

Metastatic Prostate Cancer, Pain Trial in New York, Chapel Hill (Radium-223)

Completed
  • Metastatic Prostate Cancer
  • Pain
  • Radium-223
  • New York, New York
  • +2 more
Feb 3, 2022

Metastatic Castrate Resistant Prostate Cancer Trial in Boston, Detroit, Columbus (Docetaxel, Radium 223)

Recruiting
  • Metastatic Castrate Resistant Prostate Cancer
  • Boston, Massachusetts
  • +3 more
Feb 22, 2022

Radium-223 Treated Castration Resistant Prostate Cancer Bone

Completed
  • Castration-Resistant Prostatic Cancer
  • Radium-223 dichloride, (Xofigo, BAY88-8223)
  • Multiple Locations, Germany
    (unnamed)
Nov 1, 2021

Advanced Renal Cell Carcinoma, Chromophobe Renal Cell Carcinoma, Clear Cell Renal Cell Carcinoma Trial in United States (drug,

Recruiting
  • Advanced Renal Cell Carcinoma
  • +8 more
  • Cabozantinib S-malate
  • +3 more
  • Birmingham, Alabama
  • +35 more
Jan 24, 2023